The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 332:1540-1545 June 8, 1995 Number 23
NextNext

Urinary Excretion of Aquaporin-2 in Patients with Diabetes Insipidus
Kazuo Kanno, M.D., Sei Sasaki, M.D., Yukio Hirata, M.D., San-e Ishikawa, M.D., Kiyohide Fushimi, M.D., Setsuko Nakanishi, Ph.D., Daniel G. Bichet, M.D., and Fumiaki Marumo, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Urine-concentrating ability is regulated by vasopressin. Recently, the specific water-channel protein of the renal collecting duct, known as aquaporin-2, was cloned. However, it is not certain whether this molecule is responsive to vasopressin.

Methods We measured the urinary excretion of aquaporin-2 and its response to vasopressin in 11 normal subjects and 9 patients with central or nephrogenic diabetes insipidus. The urine samples were collected during periods of dehydration and hydration and after the administration of vasopressin. Urine samples were analyzed for aquaporin-2 by the Western blot assay and immunogold labeling, and the amount of aquaporin-2 was determined by radioimmunoassay.

Results Aquaporin-2 was detectable in the urine in both soluble and membrane-bound forms. In the five normal subjects tested, the mean (±SE) urinary excretion of aquaporin-2 was 11.2±2.2 pmol per milligram of creatinine after a period of dehydration, and it decreased to 3.9±1.9 pmol per milligram of creatinine (P = 0.03) during the second hour after a period of hydration. In the six other normal subjects, an infusion of desmopressin (1-desamino-8-d-arginine vasopressin) increased the urinary excretion of aquaporin-2 from 0.8±0.3 to 11.2±1.6 pmol per milligram of creatinine (P<0.001). The five patients with central diabetes insipidus also had increases in urinary excretion of aquaporin-2 in response to the administration of vasopressin, but the four patients with X-linked or non–X-linked nephrogenic diabetes insipidus did not.

Conclusions Aquaporin-2 is detectable in the urine, and changes in the urinary excretion of this protein can be used as an index of the action of vasopressin on the kidney.


Source Information

From the Second Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, Tokyo (K.K., S.S., Y.H., K.F., F.M.); the Department of Endocrinology and Metabolism, Jichi Medical School, Tochigi (S.I.); and Pharmaceutical Basic Research Laboratories, Central Pharmaceutical Research Institute, JT Inc., Kanagawa (S.N.) — all in Japan; and the Centre de Recherche, Hôpital du Sacré-Coeur, University of Montreal, Montreal (D.G.B).

Address reprint requests to Dr. Sasaki at the Second Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-Ku, Tokyo 113, Japan.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.